Reach Us +1-217-403-9671
Na,K-ATPase Isoform-selective Cardiac Glycosides: A Potential Anti-cancer Drug? | 19788
ISSN: 0975-0851

Journal of Bioequivalence & Bioavailability
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

5th World Congress on Bioavailability and Bioequivalence Pharmaceutical R&D Summit

Adriana Katz, Cherniavsky-Lev M, Ainbinder E, Tal D and Karlish S J D
ScientificTracks Abstracts: J Bioequiv Availab
DOI: 10.4172/0975-0851.S1.017
N a, K-ATPase is present in the membrane of most eukaryotic cells and creates trans-membrane gradients of Na and K ions, which control directly or indirectly essential physiological functions of all animal cells. Regulation of this enzyme and its isoforms is believed to play a key role in various pathological processes, including cancer. The Na+, K+-ATPase consists of two subunits, α and β , in addition to a single membrane-span FXYD regulatory protein. There are four isoforms of α ( α 1-4) and three isoforms of β (β1-3), which are expressed in a tissue-specific fashion. Cardiac glycosides (CG) such as digoxin or ouabain are specific inhibitors of Na,K-ATPase. CG?s display distinct in vitro anti-cancer effects, but the full anti-cancer potential of this drug has not yet been addressed. In order to improve selectivity and affinity of cardiac glycosides for the different α isoforms of the human Na,K-ATPase we synthesized new digoxin derivatives, modified in the sugar moiety. We have investigated the effects of CG?s and the digoxin derivatives on cell growth and survival of different human cancer cell lines. The IC50 values for growth inhibition of human cancer cells in vitro are linearly correlated with the number of binding sites of NaK-ATPase and with the Ki for inhibition of the purified human NaKα1β1 complex. Together, these observations imply that the IC50 values by the different compounds are a consequence of binding to and inhibition of the pump, andquestion the potential of cardiac glycoside as selective anti-cancer drugs
Adriana Katz is an Associate Staff Scientist at the Biological Chemistry department, at Weizmann Institute of Science in Israel, with expertise in membrane proteins, structure-function and protein interactions. The research mainly involves characterization of membrane transport systems, structure and regulation. She has specialized in proteomic analysis - 2D gels, Blue native gels, membrane protein separations and identifications by Mass Spectrometry aimed to identify interacting proteins in the membrane. She is now extending her work to the mammalian Na,K-ATPase including structure-function analyses, inhibition by cardiac glycosides and drug design. She holds a PhD in Biochemistry from the Hebrew University in Jerusalem
image PDF   |   image HTML

Relevant Topics

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Business & Management Journals


[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version